TELECONFERENCE

'High-Alert Medications' Series: Part III - Preventing Errors with Insulin: A Multidisciplinary Approach

Registration for the teleconference has expired.

PROGRAM OVERVIEW

The prevalence of diabetes mellitus continues to increase at an alarming rate, spurring a corresponding increase in the use of insulin. Insulin therapy presents myriad safety concerns and the potential for medication errors. Please join us for the third part of ISMP’s High Alert Series teleconference, Preventing Errors with Insulin: A Multidisciplinary Approach, to be held on April 23, 2008 from 1:30 to 3:00 pm ET. This teleconference will explore the current trends in insulin therapy, barriers to optimal therapy and safety, and common types of errors that occur with insulin.

The following topics will be discussed:

•Patient assessment and prescribing of insulin
•Monitoring of therapy
•Use of reversal agents
•Dosing errors
•Patients receiving duplicate or concurrent therapy
•Mistakes due to similar labeling and packaging
•Mistakes due to look-alike and sound-alike drug names
•Lack of standardization of drug concentrations
•Drug storage issues

ISMP speakers will also provide examples of measures that can be used to evaluate safety practices for insulin use in your facility. Organizations that are participating in the Protect 5 Million Lives From Harm Campaign will also benefit from learning more about how to prevent harm from these targeted high-alert medications and ways to measure your success.

INTENDED AUDIENCE (Interdisciplinary teams are encouraged to attend together):

Physicians
Nurses
Pharmacists
Physician Assistants
Risk and Quality Managers
Medication Safety and Patient Safety Officers
Diabetes Educators

OBJECTIVES

Following completion of this teleconference, participants should be able to:

Describe common preventable adverse events with insulin therapy and their causes
Identify best practices that can improve safety when prescribing, dispensing, and administering insulin
Discuss the role of the practitioner in monitoring and managing the care of patients who are receiving insulin
Construct two measures that can be used to assess the safety of insulin therapy

MODERATOR

Matthew Fricker, MS, RPh, Program Director, Institute for Safe Medication Practices

SPEAKERS

Matthew Grissinger, RPh, FISMP, FASCP, Director, Error Reporting Programs, Institute for Safe Medication Practices

PRICING INFORMATION

Live Teleconference	$195.00
Live Teleconference and Teleconference CD	$225.00 (Plus $5.00 S&H)
Teleconference CD	$195.00 (Plus $5.00 S&H)
*CD includes a file of the audio recording of the teleconference as well as PowerPoint files containing slides of each presentation.

TELECONFERENCE POLICIES

Registration

One telephone line connection is allowed per registration. Others may listen on this telephone line via an internal extension, or a speakerphone may be used for larger groups.
You may not set up conferencing capabilities for other sites outside the facility. Each specific site may be used for larger groups. Each specific site must register individually.
We cannot accept registrations without an email address and the name of a contact person.
Registration for this teleconference will end at midnight ET on 4/22/2008.
CDs will be available for purchase after the teleconference.

Cancellations

Cancellations must be requested via an email message to our teleconference department.
Cancellations received before the start (1:30 pm ET) of the teleconference will receive a full refund or credit.
Cancellations received after the start (1:30 pm ET) of the teleconference and within 3 business days after the teleconference will be assessed a cancellation fee of $50.00.
If your organization does not cancel within 3 business days after the date of the teleconference and does not participate, the full registration fee will be charged.

Materials

If your organization's registered participant does not receive the teleconference materials that are sent out approximately 2 days before the teleconference via email, please send an email message to our billing department prior to the start of the teleconference.
When registering, please be sure to provide the email address of the person to whom ISMP should send these materials.

Accreditation Information:

NOTE: There is no additional charge for continuing education credits for this teleconference.

Pharmacy Continuing Education
Continuing education credits will be provided by The Pediatric Pharmacy Advocacy Group. PPAG is an approved provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education (ACPE). This program has been approved for 1.5 contact hours (0.15 CEUs). The UPN is: 180-999-08-502-L05-P.

Nursing Continuing Education
Debora Simmons is approved by the California Board of Nurse Examiners as a provider of continuing nursing education. This program has been assigned the Universal Program Number CEP 13677 and is approved for 1 contact hours (0.1 CEUs) of continuing nursing education.